grant
saveSACYL PHARMACEUTICALS, INC. — Advancing a novel on-demand non-hormonal male contraceptive to IND enablement
September 22, 2025updated 3mo ago
community read0 votes
HD grant. $399,999. PI: GREGORY S. KOPF
view source ↗HD grant. $399,999. PI: GREGORY S. KOPF
view source ↗
comments(0)
5-min edit window · permanent after that